Ritonavir & Lopinavir Suppliers & Bulk Manufacturers
Available Forms: Tablet and Oral Solution
Available Strengths: Tab: Lopinavir 200 mg + Ritonavir 50 mg; oral solution:80 mg / 20 mg per mL
Reference Brands: Kaletra(US & EU)
Category: Anti Viral
Lopinavir & Ritonavir Tablets (Kaletra®) combine two protease inhibitors for HIV treatment. Available in 200/50 mg strength, they are sourced via PharmaB2B platforms from WHO-GMP-approved manufacturers. Perfect for bulk procurement, tenders, and public health programs ensuring global access to essential HIV medicines.
Product Description:
Lopinavir & Ritonavir Tablets, widely marketed as Kaletra®, are a fixed-dose combination of two protease inhibitors used in the treatment of HIV-1 infection. Each tablet typically contains Lopinavir 200 mg and Ritonavir 50 mg, with Ritonavir boosting the effectiveness of Lopinavir. This antiretroviral combination remains vital in HIV care, especially in resource-limited settings and global treatment programs. PharmaB2B platforms connect global buyers, NGOs, and procurement agencies with WHO-GMP and USFDA-approved manufacturers offering bulk supply at competitive rates. Ideal for tenders and institutional supply, this therapy supports consistent, affordable access to HIV medications worldwide.
Ritonavir & Lopinavir — third party manufacturing & bulk supply
Ritonavir & Lopinavir is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Ritonavir & Lopinavir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Ritonavir & Lopinavir →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Ritonavir and Lopinavir are used together to treat HIV-1 infection. The combination helps reduce viral load, improve immune function, and slow the progression of HIV when used as part of antiretroviral therapy.
This combination is made from two antiretroviral agents: lopinavir, a protease inhibitor, and ritonavir, which enhances lopinavir levels by inhibiting its metabolism.
The common trade name is Kaletra.
Kaletra is manufactured by AbbVie (previously Abbott Laboratories).
The generic name is lopinavir and ritonavir.
The main brand name is Kaletra. Some regions also market it as Aluvia.
It is manufactured in various AbbVie/Abbott approved facilities, commonly in the USA, Europe, and India depending on the market and regulatory approval.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View Details
Lenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
